医学
风险分析(工程)
药品审批
自治
药品
重症监护医学
工程伦理学
药理学
法学
政治学
工程类
作者
Patricia J. Zettler,Rachel E. Sachs,Steven Joffe,Holly Fernandez Lynch
出处
期刊:JAMA
[American Medical Association]
日期:2025-03-06
标识
DOI:10.1001/jama.2025.2807
摘要
This Viewpoint argues safety and effectiveness are inseparable in US drug approval, that postmarket approaches to assess safety and effectiveness are insufficient, and that reducing the emphasis on effectiveness undermines autonomy.
科研通智能强力驱动
Strongly Powered by AbleSci AI